Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
J Vestib Res. 2021;31(2):81-90. doi: 10.3233/VES-201531.
Vertigo and dizziness are extremely common conditions in the adult population and therefore place a significant social and economic burden on both patients and the healthcare system. However, limited information is available for the economic burden of vertigo and dizziness across various health care settings.
Estimate the economic burden of vertigo and dizziness, controlling for demographic, socioeconomic, and clinical comorbidities.
A retrospective analysis of data from the Medical Expenditures Panel Survey (2007-2015) was performed to analyze individuals with vertigo or dizziness from a nationally representative sample of the United States. Participants were included via self-reported data and International Classification of Diseases, 9th Revision Clinical Modification codes. A cross-validated 2-component generalized linear model was utilized to assess vertigo and dizziness expenditures across demographic, socioeconomic and clinical characteristics while controlling for covariates. Costs and utilization across various health care service sectors, including inpatient, outpatient, emergency department, home health, and prescription medications were evaluated.
Of 221,273 patients over 18 years, 5,275 (66% female, 34% male) reported either vertigo or dizziness during 2007-2015. More patients with vertigo or dizziness were female, older, non-Hispanic Caucasian, publicly insured, and had significant clinical comorbidities compared to patients without either condition. Furthermore, each of these demographic, socioeconomic, and clinical characteristics lead to significantly elevated costs due to having these conditions for patients. Significantly higher medical expenditures and utilization across various healthcare sectors were associated with vertigo or dizziness (p < 0.001). The mean incremental annual healthcare expenditure directly associated with vertigo or dizziness was $2,658.73 (95% CI: 1868.79, 3385.66) after controlling for socioeconomic and demographic characteristics. Total annual medical expenditures for patients with dizziness or vertigo was $48.1 billion.
Vertigo and dizziness lead to substantial expenses for patients across various healthcare settings. Determining how to limit costs and improve the delivery of care for these patients is of the utmost importance given the severe morbidity, disruption to daily living, and major socioeconomic burden associated with these conditions.
眩晕是成年人中极其常见的病症，因此会给患者和医疗保健系统带来巨大的社会和经济负担。然而，关于各种医疗保健环境下眩晕的经济负担，信息十分有限。
控制人口统计学、社会经济学和临床合并症，估算眩晕的经济负担。
对 2007-2015 年医疗支出调查（Medical Expenditures Panel Survey）的数据进行回顾性分析，以分析美国全国代表性样本中出现眩晕的个体。通过自我报告数据和国际疾病分类第 9 版临床修正码纳入参与者。使用交叉验证的两分量广义线性模型，在控制协变量的同时，评估人口统计学、社会经济学和临床特征对眩晕支出的影响。评估了各种医疗保健服务部门的成本和使用情况，包括住院、门诊、急诊、家庭保健和处方药。
在 221273 名 18 岁以上的患者中，有 5275 名（66%为女性，34%为男性）报告在 2007-2015 年期间出现眩晕。与没有任何一种情况的患者相比，患有眩晕的患者中女性、年龄较大、非西班牙裔白种人、有公共保险且有显著临床合并症的比例更高。此外，这些人口统计学、社会经济学和临床特征都会导致患者因患有这些疾病而产生显著更高的成本。患有眩晕或头晕的患者在各种医疗保健领域的医疗支出和利用率均显著升高（p<0.001）。在控制社会经济和人口统计学特征后，与眩晕或头晕直接相关的平均年度医疗保健增量支出为 2658.73 美元（95%CI：1868.79，3385.66）。患有头晕或眩晕的患者的年总医疗支出为 481 亿美元。
眩晕会给患者带来各种医疗保健环境下的大量费用。鉴于这些病症会导致严重的发病率、日常生活中断和重大的社会经济负担，确定如何限制这些患者的成本并改善对这些患者的护理至关重要。
